Subepithelial mucinous corneal dystrophy

{{Infobox medical condition (new)

| name = Subepithelial mucinous corneal dystrophy

| synonyms =

| image = Subepithelial mucinous corneal dystrophy 1.JPEG

| caption = A diffuse haziness is present in the papillary region of the cornea in association with discrete opacities. (Reproduced in Klintworth et al. with permission from Feder et al.)

| pronounce =

| field = ophthalmology

| symptoms =

| complications =

| onset =

| duration =

| types =

| causes =

| risks =

| diagnosis =

| differential =

| prevention =

| treatment =

| medication =

| prognosis =

| frequency =

| deaths =

}}

Subepithelial mucinous corneal dystrophy (SMCD), a condition of the eye, is a rare form of corneal dystrophy. It was first described in 1993 by Feder et al.{{cite journal |vauthors=Feder RS, Jay M, Yue BY, Stock EL, O'Grady RB, Roth SI |title=Subepithelial mucinous corneal dystrophy. Clinical and pathological correlations |journal=Arch. Ophthalmol. |volume=111 |issue=8 |pages=1106–14 |date=August 1993 |pmid=8352693 |doi= 10.1001/archopht.1993.01090080102025|url=http://archopht.ama-assn.org/cgi/pmidlookup?view=long&pmid=8352693 |archive-url=https://archive.today/20110810032207/http://archopht.ama-assn.org/cgi/pmidlookup?view=long&pmid=8352693 |url-status=dead |archive-date=2011-08-10 |url-access=subscription }} Anterior to Bowman layer, deposits of glycosaminoglycan were detected and identified as chondroitin-4-sulfate and dermatan sulfate.